131 related articles for article (PubMed ID: 19963602)
1. Comparison and unification of genomic signatures in breast cancer.
Blazadonakis ME; Zervakis ME
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():3869-72. PubMed ID: 19963602
[TBL] [Abstract][Full Text] [Related]
2. Complementary gene signature integration in multiplatform microarray experiments.
Blazadonakis ME; Zervakis ME; Kafetzopoulos D
IEEE Trans Inf Technol Biomed; 2011 Jan; 15(1):155-63. PubMed ID: 20813648
[TBL] [Abstract][Full Text] [Related]
3. Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
Miller LD; Liu ET
Breast Cancer Res; 2007; 9(2):206. PubMed ID: 17397520
[TBL] [Abstract][Full Text] [Related]
4. Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG study.
Kempowsky-Hamon T; Valle C; Lacroix-Triki M; Hedjazi L; Trouilh L; Lamarre S; Labourdette D; Roger L; Mhamdi L; Dalenc F; Filleron T; Favre G; François JM; Le Lann MV; Anton-Leberre V
BMC Med Genomics; 2015 Feb; 8():3. PubMed ID: 25888889
[TBL] [Abstract][Full Text] [Related]
5. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
Bueno-de-Mesquita JM; van Harten WH; Retel VP; van 't Veer LJ; van Dam FS; Karsenberg K; Douma KF; van Tinteren H; Peterse JL; Wesseling J; Wu TS; Atsma D; Rutgers EJ; Brink G; Floore AN; Glas AM; Roumen RM; Bellot FE; van Krimpen C; Rodenhuis S; van de Vijver MJ; Linn SC
Lancet Oncol; 2007 Dec; 8(12):1079-1087. PubMed ID: 18042430
[TBL] [Abstract][Full Text] [Related]
6. Genes and functions from breast cancer signatures.
Huang S; Murphy L; Xu W
BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
[TBL] [Abstract][Full Text] [Related]
7. Improved breast cancer prognosis through the combination of clinical and genetic markers.
Sun Y; Goodison S; Li J; Liu L; Farmerie W
Bioinformatics; 2007 Jan; 23(1):30-7. PubMed ID: 17130137
[TBL] [Abstract][Full Text] [Related]
8. A simple but highly effective approach to evaluate the prognostic performance of gene expression signatures.
Starmans MH; Fung G; Steck H; Wouters BG; Lambin P
PLoS One; 2011; 6(12):e28320. PubMed ID: 22163293
[TBL] [Abstract][Full Text] [Related]
9. Effects of sample size on robustness and prediction accuracy of a prognostic gene signature.
Kim SY
BMC Bioinformatics; 2009 May; 10():147. PubMed ID: 19445687
[TBL] [Abstract][Full Text] [Related]
10. An algorithm to discover gene signatures with predictive potential.
Hallett RM; Dvorkin A; Gabardo CM; Hassell JA
J Exp Clin Cancer Res; 2010 Sep; 29(1):120. PubMed ID: 20813028
[TBL] [Abstract][Full Text] [Related]
11. Cross-study projections of genomic biomarkers: an evaluation in cancer genomics.
Lucas JE; Carvalho CM; Chen JL; Chi JT; West M
PLoS One; 2009; 4(2):e4523. PubMed ID: 19225561
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer genomics: real-time use.
Bertucci F; Birnbaum D
Lancet Oncol; 2007 Dec; 8(12):1045-1047. PubMed ID: 18054870
[No Abstract] [Full Text] [Related]
13. From description to causality: mechanisms of gene expression signatures in cancer.
Adler AS; Chang HY
Cell Cycle; 2006 Jun; 5(11):1148-51. PubMed ID: 16721055
[TBL] [Abstract][Full Text] [Related]
14. Hunting for robust gene signature from cancer profiling data: sources of variability, different interpretations, and recent methodological developments.
Xu JZ; Wong CW
Cancer Lett; 2010 Oct; 296(1):9-16. PubMed ID: 20579805
[TBL] [Abstract][Full Text] [Related]
15. Derivation of cancer diagnostic and prognostic signatures from gene expression data.
Goodison S; Sun Y; Urquidi V
Bioanalysis; 2010 May; 2(5):855-62. PubMed ID: 21083217
[TBL] [Abstract][Full Text] [Related]
16. NETBAGs: a network-based clustering approach with gene signatures for cancer subtyping analysis.
Wu L; Liu Z; Xu J; Chen M; Fang H; Tong W; Xiao W
Biomark Med; 2015; 9(11):1053-65. PubMed ID: 26501477
[TBL] [Abstract][Full Text] [Related]
17. Integration of gene signatures using biological knowledge.
Blazadonakis ME; Zervakis ME; Kafetzopoulos D
Artif Intell Med; 2011 Sep; 53(1):57-71. PubMed ID: 21767937
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive sensitivity analysis of microarray breast cancer classification under feature variability.
Sontrop HM; Moerland PD; van den Ham R; Reinders MJ; Verhaegh WF
BMC Bioinformatics; 2009 Nov; 10():389. PubMed ID: 19941644
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of gene expression profile signatures in early-stage breast cancer.
Desmedt C; Sotiriou C; Piccart-Gebhart MJ
Cancer Invest; 2009 Jan; 27(1):1-10. PubMed ID: 19191098
[No Abstract] [Full Text] [Related]
20. Optimizing molecular signatures for predicting prostate cancer recurrence.
Sun Y; Goodison S
Prostate; 2009 Jul; 69(10):1119-27. PubMed ID: 19343730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
